Genome-wide association studies (GWASs) have identified many disease associated loci, the 14 majority of which have unknown biological functions. Understanding the mechanism underlying 15 trait associations requires identifying trait-relevant tissues and investigating associations in a 16 trait-specific fashion. Here, we extend the widely used linear mixed model to incorporate 17 multiple SNP functional annotations from omics studies with GWAS summary statistics to 18 facilitate the identification of trait-relevant tissues, with which to further construct powerful 19 association tests. Specifically, we rely on a generalized estimating equation based algorithm for 20 parameter inference, a mixture modeling framework for trait-tissue relevance classification, and 21 a weighted sequence kernel association test constructed based on the identified trait-relevant 22 tissues for powerful association analysis. We refer to our analytic procedure as the Scalable 23 Multiple Annotation integration for trait-Relevant Tissue identification and usage (SMART). 24 With extensive simulations, we show how our method can make use of multiple complementary 25 annotations to improve the accuracy for identifying trait-relevant tissues. In addition, our 26 procedure allows us to make use of the inferred trait-relevant tissues, for the first time, to 27 construct more powerful SNP set tests. We apply our method for an in-depth analysis of 43 traits 28 from 28 GWASs using tissue-specific annotations in 105 tissues derived from ENCODE and 29 Roadmap. Our results reveal new trait-tissue relevance, pinpoint important annotations that are 30 informative of trait-tissue relationship, and illustrate how we can use the inferred trait-relevant 31 tissues to construct more powerful association tests in the Wellcome trust case control 32 consortium study. 33 34 Key words 35 genome-wide association studies, summary statistics, functional annotations, complex traits, 36 trait-relevant tissue, linear mixed model, generalized estimating equation, mixture model, SNP 37 set test 38 2 / 37 Author Summary 39 40
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compared with analyzing one annotation at a time, analyzing multiple annotations jointly can 149 improve power for the identification of trait-relevant tissues. In addition, we show that, using 150 parameter estimates from inferred trait-relevant tissues as SNP weights leads to more powerful 151 SNP set tests than the standard SKAT [49] [50] [51] . We apply our method for an in-depth analysis of 152 43 GWAS traits with multiple functional annotations in more than one hundred tissues derived 153 from ENCODE and Roadmap. We show how our method and analysis can help provide 154 biological insights for the genetic basis of complex traits and benefit future association studies. 155 The SMART method is implemented as an R package, freely available at 156 http://www.xzlab.org/software.html. 7 / 37 roughly following [16] , where E represents prior expectation. The intercept 0 effectively 200 determines how large a typical SNP effect size would be, while the other annotation coefficients 201 determine how the SNP effect size variance would vary around the average depending on what 202 annotations the SNP has. Note that the assumed linear relationship between the SNP specific 203 variance and annotations also naturally extends the modeling assumptions made in LDSC [16] 204 and MQS [48] , both of which examine one annotation at a time in the presence of multiple 205 binary annotations, though LDSC has also been recently extended to examine one annotation at a 206 time in the presence of continuous annotations [31] . In addition, our polygenic modeling 207 assumption complements alternative approaches in using sparse models for integrating functional 208 annotations [11, 12, 40, 53] . 209 210 For inference on the annotation coefficients ( ), we follow the main idea of LDSC and MQS in 211 using the marginal 2 statistics. Using marginal statistics allows our method to be applied to data 212 where only summary statistics are available. Unlike the detailed algorithms of LDSC or MQS 213 that were initially designed to examine one annotation at a time in the presence of multiple 214 binary annotations, however, we applied the generalized estimating equation (GEE) [46, 54] 215 inference method that allows for the joint inference of multiple binary and continuous 216 annotations (details in Supplementary Text). GEE is widely used for modeling correlated data 217 and is particularly suitable here to account for the correlation among the marginal 2 statistics 218 due to linkage disequilibrium. In the case of binary annotations, the results of our GEE on each 219 annotation by using a diagonal matrix as the working covariance matrix can reduce to that of 220 LDSC and MQS, while the results of our GEE by using an LD based general working covariance 221 matrix can reduce to that of polyGEE [47] . Importantly, just like other summary statistics based 222 methods, GEE inference can be carried out using summary statistics that include marginal 2 223 statistics and the m by m SNP correlation matrix. The SNP correlation matrix can be obtained 224 from a reference panel, by using, for example, the genotypes from the 1,000 Genomes Project 225 [55]. To facilitate both computation and memory storage, we further approximate the SNP 226 correlation matrix by a block diagonal matrix (details in Supplementary Text), allowing us to 227 capture the main block-wise linkage disequilibrium pattern commonly observed in the human 228 genome [40, [56] [57] [58] . Finally, with GEE, we obtain both point estimates ̂ and their variance (̂) 229 for all annotation coefficients in a closed form. We can then compute the multivariate Wald 230 statistic ̂(̂) −1̂ which can be used as a measurement of trait-tissue relevance. 231 232 Previous approaches to identify trait-relevant tissues examines one (univariate) Wald statistics at 233 a time, and uses an asymptotic normal test to obtain a p-value to identify significant trait-tissue 234 pairs. Because one annotation in one tissue is often highly correlated with the same annotation in 235 other tissues as well as other annotations in other tissues, the p-values for even the trait-irrelevant 236 tissues are often significant due to the annotation correlation across annotations and tissues. 237 Indeed, as previous studies have shown, even in simple simulations, trait-irrelevant tissues can be 238 falsely identified as trait-relevant in 20% of the simulation replicates [16] . As a consequence, 239 previous studies have to use a set of baseline annotations as covariates to reduce the cross-tissue 240 correlation among annotations, thus reducing false positives. However, it is often unclear how 241 many and what types of baseline variables one should include for a given data set: using a small 242 number of baseline covariates may not control for false positives well, while using a large 243 number of covariates may reduce the power to detect the true trait-relevant tissues. Indeed, the 244 use of baseline variables seems to be highly dependent on data sets (with varying sample sizes 245 8 / 37 and SNP numbers), and needs adjustment in different data sets to achieve sensible results [16] . 246 247 Here, we present an alternative strategy for identifying trait-relevant tissues. Specifically, for 248 each trait in turn, we model the multivariate Wald statistics across tissues with a mixture of two 249 non-central chi-squared distributions to classify tissues into two groups. The two non-central chi- 250 squared distributions have the same degrees of freedom that equals to the number of annotations 251 fitted in GEE (i.e. c), but different noncentrality parameters. The chi-squared distribution with 252 the small noncentrality parameter represents the empirical null distribution that contains tissues 253 irrelevant to the trait. The small, nonzero, noncentrality parameter characterizes the fact that 254 these irrelevant tissues tend to have Wald statistics larger than what would be expected under the 255 theoretical null distribution (i.e. central chi-squared) simply due to annotation correlation across 256 tissues. In contrast, the chi-squared distribution with the large non-central parameter represents 257 the alternative model that contains tissues relevant to the trait. The large noncentrality parameter 258 characterizes the fact that these relevant tissues tend to have Wald statistics larger than those 259 from the irrelevant tissues. By classifying tissues into two groups, we can identify tissues with 260 strong trait-relevance without the need to explicitly model the empirical null distribution using a 261 data generative model. Therefore, our strategy effectively formulates the task of identifying trait-262 relevant tissues as a classification problem instead of a testing problem. By modeling the 263 empirical null distribution directly, we can reduce false discoveries and potentially gain power at 264 a given false discovery rate (FDR). We also note that this classification strategy follows closely 265 recent applications of mixture models to estimate the empirical null distribution in other 266 genomics settings [59, 60] . Technically, we use the expectation-maximization (EM) algorithm to 267 fit the mixture model and infer the two noncentrality parameters as well as the proportion of 268 alternatives from data at hand (details in the Supplementary Text). For each tissue in turn, we 269 then obtain the inferred posterior probability (PP) of it being in the alternative model as its 270 evidence for trait-relevance. We use these inferred posterior probabilities (ranging between 0 and 271 1) for all following analyses. Note that while our linear mixed model itself does not explicitly 272 model the correlation structure among annotations across tissues by incorporating all annotations 273 from all tissues into a single model, our mixture model and classification strategy can implicitly 274 account for the annotation correlation across tissues.
276
Finally, we ask the question of how to make use of the inferred trait-relevant tissues to enable 277 more powerful future association studies. We note that our model defined in equations (1) and 278 (2) is closely related to the sequence kernel association test (SKAT) model [49] [50] [51] Table S1 ). For each tissue and each histone mark in turn, we created a binary histone mark 309 annotation indicating whether the SNP resides inside the peak regions of the histone mark. The 310 average proportions of SNPs residing in each of the four mark labeled regions across the 105 311 tissues are 25.75% for H3K27me3, 18.51% for H3K36me3, 17.98% for H3K4me1, 10.69% for 312 H3K4me3 (Table S1 ). In addition to the binary annotations, for each tissue group and each 313 histone mark in turn, we averaged the binary annotation indicator across all tissue types within 314 the tissue group and used the average value as a new, continuous, tissue group level histone mark 315 annotation. Therefore, we obtained both tissue-specific binary histone mark annotations and 316 tissue-group-specific continuous histone mark annotations. We performed two sets of simulations to illustrate the benefits of our method in terms of (1) SNPs with a missingness percentage above 0.05, a minor allele frequency (MAF) below 0.05, 335 and a Hardy-Weinberg equilibrium test p-value below 10 -4 . We then randomly selected 10,000 336 individuals with European ancestry, and obtained the first 27,640 (or 10,000) SNPs on chromosome one to perform the first (or the second) set of simulations.
339
For the first set of simulations, we obtained two histone marks (H3K4me1 and H3K4me3) from 340 ten different tissue groups from the ENCODE and Roadmap projects, and used them as SNP 341 annotations (details in the previous subsection). Among the ten tissue groups, we randomly 342 selected one as the trait-relevant tissue group in each simulation replicate. We designated all 343 SNPs to be causal, and simulated the causal SNP effects independently from a normal 344 distribution with a SNP-specific variance determined by annotations in the trait-relevant tissue. 345 In particular, we set the variance intercept (i.e. α 0 ) to be 0.1 and we varied each of the two 346 annotation coefficients (i.e. α 1 , 2 ) from -0.1 to 0.5 (-0.1/0/0.05/0.1/0.25/0.5) to cover a range of 347 possible values estimated from real data (details in Real Data Applications). We performed 1,000 348 simulation replicates for each combination of the two annotation coefficients (α 1 , 2 ). Note that 349 the median estimates of the two annotations across 43 GWAS traits (details in Real Data 350 Applications) is close to (α 1 , 2 ) = (0.1, 0.05). We simulated the residual errors from a normal 351 distribution with variance 0.9, so that the resulting trait has a SNP heritability of 0.1, which 352 corresponds to the median SNP heritability estimate across 43 traits in the real data analysis. We Figure S1 ). In the main text, we used simulations to illustrate the benefits of 364 modeling multiple annotations jointly. 365 366 For the second set of simulations, we used 10,000 SNPs and divided them into 100 blocks with 367 100 SNPs inside each block. For the null simulations, we set the effect sizes of all SNPs to be 368 zero and performed 50,000 simulation replicates. For the alternative simulations, we randomly 369 selected 10 non-adjacent blocks as causal blocks and we randomly selected 20% SNPs inside 370 these causal blocks to be causal SNPs (i.e. a total of 200 causal SNPs). We then simulated ten 371 tissue-specific annotation sets, each with two annotations, which are simulated to correlate with 372 SNP causality [30] . Specifically, the annotation values for the non-causal SNPs are sampled from 373 a normal distribution with mean 0 and variance 1. The causal SNPs are randomly divided into 374 three groups: for the first annotation, its annotations values for the first group are sampled from a 375 normal distribution with mean 0 and variance 1 while its annotations values for the second and 376 third groups are sampled from a normal distribution with mean 10 and variance 1; for the second 377 annotation, its annotations values for the second group are sampled from a normal distribution 378 with mean 0 and variance 1 while its annotations values for the first and third groups are sampled 379 from a normal distribution with mean 10 and variance 1. The proportion of the three groups of 380 causal SNPs are set to be either (1/2, 1/2, 0), (1/3, 1/3, 1/3) or (0, 0, 1). Because two annotations 381 share similar annotation values in the third group of causal SNPs, the proportion of the third 382 group determines the correlation between the two annotations for causal SNPs within the annotation set. Therefore, the selected proportion of the third group SNPs being 0, 33% and 384 100% correspond to low, median and high correlation between the two annotations in causal 385 SNPs, respectively. Once we had the annotations, we simulated the effect sizes for causal SNPs 386 independently from a normal distribution with a SNP-specific variance determined by the 387 designated annotation set. Specifically, we set α 0 = 0.5 and chose either (α 1 , α 2 ) = (0.4, 0.4) (in 388 the case of two informative annotations) or (α 1 , α 2 ) = (0.4, 0) (in the case of one informative 389 annotation). These parameters were selected to ensure that the 10 causal blocks explain a large 390 proportion of variance in phenotypes (per-block PVE > 0.01; Figure S2 ) so that we will have 391 reasonable power to detect them. Certainly, power is a continuous function of per-block PVE and 392 is non-zero even for small values of per-block PVE. We simulated the residual errors from a 393 normal distribution with variance 0.5. We summed all genetic effects and the residual errors 394 together to form the simulated phenotypes. We then randomly divided the 10,000 individuals into 395 two sets: a training set with 7,000 individuals and a test set of 3,000 individuals. In the training 396 set, we followed the same procedure described in the previous paragraph to obtain marginal 2 397 statistics in the data and SNP correlation matrix from a reference panel to fit our model. We resulting SNP weights would equal to the equal weights due to a small PP value and would thus 408 still be effective in the subsequent SNP set analysis. We finally applied the SNP weights 409 constructed in the training data to the test data to perform SNP set analysis. We performed 1,000 410 simulation replicates for each alternative simulation setting. We divided these replicates into 10 411 sets, each with 100 replicates, and computed the power to detect the causal blocks in each set. 412 We report the mean and variance of these power values across 10 sets. 413 414
GWAS Summary Statistics

416
We obtained summary statistics in the form of marginal z-scores for 43 traits from 28 GWAS 417 studies. Details are provided in Table S2 . These studies collect a wide range of complex traits 418 and diseases that can be classified into six phenotype categories [28, 65] : anthropometric traits 419 (e.g. height and BMI), hematological traits (e.g. MCHC and RBC), autoimmune diseases (e.g. 420 CD and IBD), neurological diseases (e.g. Alzheimer's disease and Schizophrenia), metabolic 421 traits (e.g. FG and HDL), and social traits (e.g. ever smoked and college completion). We 422 removed SNPs within the major histocompatibility complex (MHC) region (Chr6: 25Mb-34Mb) 423 following [16] . We then intersected the SNPs from all the studies and retained a common set of 424 622,026 SNPs for analysis. We paired the marginal z-scores from these studies with the SNP 425 correlation matrix estimated using 503 individuals of European ancestry from the 1,000 426 Genomes Project [55] for inference. Finally, after the analysis, we computed correlation among 427 traits in terms of their tissue relevance and used the Bayesian information criterion (BIC) 428 implemented in the clustering package mclust [66] in R with the standard option EEI to classify traits. Clustering with BIC automatically inferred a total of five main trait clusters. 432   433 We rely on previous literature to partially validate the inferred trait-relevant tissue results in real 434 data. We reasoned that, if a tissue is indeed relevant to a given trait, then there would be 435 extensive prior biomedical researches carried out on the tissue for the trait. Therefore, the The number of publications on each trait-tissue pair from the PubMed search is listed in Table S3 453 (the search was carried out on June 23, 2017). For each trait in turn, we further normalized the 454 data by dividing the number of publications for a tissue by the total number of publications 455 across all tissues for the trait. We used the resulting proportion for the final analysis. 476 We removed SNPs with a Hardy-Weinberg equilibrium p-value < 10 -4 or a minor allele 477 frequency < 0.05, and intersected SNPs from WTCCC with the consortium data to obtain a final 478 set of 335,170 overlapped SNPs. Meanwhile, we obtained genome locations for a set of 19,189 479 protein coding genes from GENCODE project [72] . We intersected SNPs with these genes and 480 identified gene-harboring SNPs that reside within 10 kb upstream of the transcription start site 481 and 10 kb downstream of the transcription end site. To perform gene-set test, we focused on 482 5,588 genes that have at least 10 SNPs, with an average of 29.6 SNPs inside each gene and a 483 total of 153,813 gene-harboring SNPs. For each gene in turn, we computed SNP-specific 484 variance using annotation coefficient estimates from the best trait-relevant tissue inferred with 485 consortium study summary statistics for the corresponding trait. We used the SNP-specific show that the power of SMART increases with increasing annotation coefficients, is not sensitive 540 to the signs of annotations, and is relatively stable with respect to the genome-occupancy of the 541 annotations as we have standardized the annotations to have mean zero and standard deviation 542 one across the genome ( Figure S3 ).
431
Investigate Trait-Tissue Relevance via PubMed Search
544
We examine in detail a simulation setting where ( 1 , 2 ) are chosen to be close to the median 545 estimates (0.1, 0.05) from the real data sets (i.e. gold shade in Figure 1A and Figure S1 ). Note 546 that even though these parameters are chosen based on real data, we have much less SNPs or 547 samples in the simulations than in real data and are thus underpowered in simulations. In any 548 case, we first obtained annotation coefficient estimates (̂1,̂2) across simulation replicates in 549 this setting. We found that the estimates are centered around the truth as one would expect 550 ( Figure 1B ), suggesting accurate parameter estimation by our approach. Next, in addition to the 551 six approaches listed above, we also included a UniMax_LDSC approach into comparison. In the 552 UniMax_LDSC approach, we applied LDSC to analyze one trait at a time and used the 553 maximum Wald statistics among the two to measure trait-tissue relevance. Different from the 554 UniMax_Wald, however, UniMax_LDSC used a set of 75 baseline annotations to address 555 correlation among annotations. As a result, UniMax_LDSC performs similarly as UniMax in 556 terms of power to detect trait relevant tissues at different FDR thresholds ( Figure 1C ), suggesting 557 that using mixture modeling is competitive compared to using covariates to control for 558 annotation correlation across tissues. Because both UniMax_LDSC and UniMax use only one 559 annotation, they are often less powerful compared to SMART that models two annotations 560 together ( Figure 1C ).
562
Simulations: Construct Powerful SNP Set Test
564
Our second set of simulations is intended to illustrate the benefits of our method in using inferred 565 trait-relevant tissue to enable more powerful SNP set tests. Here, we ask the question of how to 566 make use of the inferred trait-relevant tissues to enable more powerful future association studies. ], we obtained 10,000 SNPs from the same set of 10,000 individuals in the GERA study 577 [63,64] and simulated phenotypes (Materials and Methods). To do so, we divided these SNPs 578 evenly into 100 blocks and randomly selected 10 blocks to be causal blocks. In each casual 579 block, we further selected 20 SNPs to be causal SNPs. We then simulated ten tissue-specific 580 annotation sets with two annotations within each set and designated one set as the trait-relevant 581 tissue. We simulated causal SNP effect sizes based on the two annotations from the trait-relevant 582 tissue and added residual errors to form the simulated phenotypes. Afterwards, we divided 583 individuals randomly into two sets: a training set of 7,000 individuals and a test set of 3,000 584 individuals. We applied SMART_EM and UniMax_EM in the training set to identify trait-relevant tissues and to estimate annotation coefficients. We then applied the following weighting 586 options to perform SKAT [49-51] analysis in the test set: 587 (1) EqualWeight, where we weight all SNPs equally. 588 (2) TissueWeight_Oracle, where we use the true coefficients from the correct trait-relevant tissue 589 to construct SNP weights. This represents an up limit of power we can possibly achieve. 590 (3) TissueWeight_SMART, where we fitted SMART_EM in the training data and applied the 591 coefficient estimates for the two annotations in the inferred trait-relevant tissue to construct SNP 592 weights. 593 (4) TissueWeight_UniMax, where we fitted UniMax_EM in the training data and applied the 594 coefficient estimate for the annotation with the larger Wald statistics in the inferred trait-relevant 595 tissue to construct SNP weights.
597
We first simulated 50,000 replicates under the null where there is no causal SNP so that both α 0 598 and (α 1 , α 2 ) are 0. We used the null simulations to examine the type I error control for various 599 methods and we found that all these methods are well behaved (Figure 2A ). Next, we simulated 600 1,000 replicates under the alternative where we have non-zero α 0 and (α 1 , α 2 ). We divided SNPs 601 into 100 blocks, among which 10 are causal. We compared different methods in terms of their 602 power to identify the causal blocks. In the simulations, we generated two annotations whose TissueWeight_UniMax, when both annotations have non-zero coefficients, we found that using 617 multiple annotations often leads to greater power gain than using a single annotation. However, 618 as one would expect, when the two annotations contain overlapping information (e.g. in the case 619 of 100%), then using one annotation yields similar power as using two annotations (green vs blue 620 in Figure 2B ). In the special case where only one annotation has a non-zero coefficient, then 621 using multiple annotations also has similar power compared with using a single annotation, even 622 when the two annotations contain complementary information (green vs blue in Figure 2C ).
624
Next, we explore how various simulation parameters influence the weighted SKAT power To further characterize trait-tissue relevance at the tissue level, we examined the results from the 769 HB approach in details. The annotation set (1) contains binary annotations for 105 tissues that 770 belong to 10 tissue groups. We have only focused on examining group-level results from this set 771 of annotations so far. Here, we focus instead on the PP values for the 105 tissues directly; thus 772 we have a 105-vector of PP values for every trait. We relied on the PP values to rank tissues for 773 every trait. The tissue rank list for each trait represents the tissue footprint of each trait: the trait-774 relevant tissues are ranked high in the list while the trait-irrelevant tissues are ranked low in the 775 list. With the tissue rank list, we assess the similarity between GWAS traits in terms of their tissue relevance by hierarchical clustering (Figure 4 ). We also computed pair-wise spearman 777 correlation between traits based on the tissue rank list ( Figure 5 ). Overall, applying the Bayesian Finally, we explored the use of annotation coefficient estimates from the inferred trait-relevant 808 tissues to construct SNP set tests in a separate data, the Wellcome trust cast control consortium 809 (WTCCC) study. WTCCC contains the six common diseases that include T1D, T2D, CD, BIP, 810 RA and CAD. We focused on a set of 5,588 genes and used 153,813 SNPs inside these genes to 811 perform SNP set test using SKAT [49-51] (details in Materials and Methods). As in simulations, 812 we considered three different SNP weights for SKAT test: (1) SNP weights constructed by the 813 multivariate analysis approaches of SMART (i.e. HC and HB); (2) SNP weights constructed by 814 the univariate maximal statistics approach (HCuMax, HBuMaxLDSC and HBuMax); and (3) 815 equal SNP weights (EqualWeight). We apply different weights to each of the six diseases. We 816 first display the quantile-quantile (QQ) plot of -log10 p-values from SKAT in Figure 6 (for CD) 817 and Figure S6 (for T1D, T2D, BIP, RA and CAD), which, consistent with simulations, suggests 818 proper control of type I error. In the analysis, different approaches identified a different number 819 of associated genes that pass the Bonferroni corrected genome-wide significance threshold 820 (8.95x10 -6 ), and these numbers range from 12-15 (the union of them contains 17 genes). These 821 genes are associated with either CD, RA, T1D or T2D, and have all been validated either in the 822 original WTCCC study or in other GWASs of the same trait (Table 1) . Consistent with 22 / 37 simulations, we found that SNP set tests using weights constructed from the trait-relevant tissue 824 achieves higher power compared with using equal weights. For example, the HC approach or the 825 HB approach identified 15 genes, 3 more than that identified using equal weights (Table 1) neither of these were identified by the equal weights approach. Finally, within each annotation 830 set, using multiple annotations identified slightly more genes than using one annotation at a time 831 (i. e. HB vs. HBuMax or HBuMaxLDSC and HC vs. HCuMax) , again consistent with the 832 simulation results.
Discussion
835
We have presented a simple modification of the commonly used linear mixed model to integrate 836 multiple SNP annotations with GWAS traits to facilitate the identification of trait-relevant 837 tissues. We have described an accompanying GEE based parameter inference algorithm that 838 makes use of summary statistics and naturally accounts for genetic correlation due to linkage 839 disequilibrium. We have shown how the task of identifying trait-relevant tissues can be is often interpreted as the posterior probability of being a "causal" or "functional" SNP. While 853 these synthetic annotations have the benefits of simplicity and potential interpretability, they 854 often have the drawback of being derived without taking into account the GWAS trait of interest. 855 Arguably, functions of genetic variants depend on traits and clustering SNPs without considering 856 the trait of interest may be suboptimal. Our approach complements these previous methods in 857 that we effectively derive a synthetic annotation by taking GWAS traits into account. In 858 particular, our method can be viewed as a supervised approach to combine multiple annotations 859 into a single annotation, where the single annotation is represented as a weighted summation of 860 the multiple annotations, with the weights being the estimated annotation coefficients inferred 861 directly using the GWAS trait. Therefore, the approach we develop effectively takes the trait of 862 interest into account. Certainly, both our approach and these previous approaches make a key 863 modeling assumption that multiple annotations in the trait-relevant tissue are more relevant to 864 SNP effect sizes or causality as compared with annotations in trait-irrelevant tissues. While it is a 865 reasonable assumption for histone occupancy based annotations we examine here, this 866 assumption may not hold well for certain annotations and for certain complex traits. For 867 example, it is possible the classification of trait-relevant tissue depends on what annotation one 868 examines: the SNP effect sizes can be predicted well by using one annotation in one tissue, or by 869 using another annotation in a different tissue. To briefly explore the utility of our method in the 870 case of multiple trait-relevant tissues, we performed a simulation study that is similar to the 871 polygenic scenario presented in the results section but with two trait-relevant tissues: we used 872 one annotation from one tissue and another annotation from another tissue to simulate SNP effect 873 sizes. In this setting, as one might expect, the difference between the multivariate approach and 874 the univariate approach is small ( Figure S7 ). Therefore, developing method for the case of 875 multiple trait-relevant tissues is an interesting future direction.
877
We rely on a polygenic model to evaluate the contribution of annotations to SNP effect sizes and 878 infer trait-relevant tissues. Our polygenic model assumes that all SNP effect sizes are non-zero and follow a normal distribution with SNP-specific variance that is a function of multiple 880 annotations. Therefore, our approach is different from several previous approaches that rely on a 881 sparse model to evaluate the contribution of annotations to SNP causality [11, 12, 27, 28, 40, 53] . 882 While sparse models can be used to directly link annotation coefficients to the causality of SNPs, 883 they often encounter severe computational burdens due to linkage disequilibrium among SNPs. 884 For example, the recent sparse model bfGWAS [40] has to divide genome into thousands of 885 approximately independent blocks and perform analysis within each block separately; and even 886 with such a simplified algorithm it can take a sparse model days to analyze a GWAS data with 887 tens of thousands of individuals and millions of SNPs. In contrast, a key advantage of our 888 polygenic model and its GEE based inference algorithm is their ability to properly account for 889 linkage disequilibrium while being computationally trackable. Indeed, it only take about 20 890 minutes to analyze each of trait-tissue pair in our real data application with hundreds of 891 thousands of individuals and millions of SNPs. Certainly, the polygenic modeling assumption 892 that all SNPs have non-zero effects may not be realistic for certain traits and developing both 893 realistic and computationally efficient methods is an important future direction.
895
We have focused primarily on using tissue-specific annotations based on histone occupancy from 896 the ENCODE and ROADMAP projects. Other tissue-specific annotations are nowadays readily 897 available. For example, the GTEx project measures expression quantitative trait loci (eQTL) 898 information in 53 tissues, many of which overlap with that in ROADMAP. Our method can 899 easily incorporate multiple annotations from different data sources and include both eQTL 900 annotations from GTEx and histone annotations from ROADMAP, though caution needs to be 901 made to account for accuracy difference in these eQTL annotations from different tissues due to 902 sample size variation. In any case, jointly analyzing multiple sources of annotations will likely 903 improve power further in identifying trait-relevant tissues in the future. 904 905 In the real data application, we have attempted to infer fine-scale trait-tissue relevance by using 906 105 tissues instead of the 10 tissue groups using the HB approach. The inferred top-ranking 907 tissue types from the HB approach for each of the 43 GWAS traits are listed in Supplementary   908   Table S5 . As expected, most of these top-ranking tissues belong to the top-ranking tissue group 909 (median = 70.5% across traits), suggesting relatively stable inference results whether tissues or 910 tissue groups were used in the analysis. For example, all of the top-ranking tissues (with PP > 911 0.5) for ever smoked and YE belong to the CNS tissue group, and 28 of the 39 top-ranking 912 tissues for CD belong to the blood immune tissue group. We have attempted to further quantify 913 the tissue-level relevance results by comparing them to the corresponding PubMed search 914 results, as we have done in the main text for the tissue group analysis. However, we found that 915 PubMed search results are unable to distinguish fine-scale tissue types for most traits. Therefore, 916 we had to rely on prior biology knowledge obtained in various other studies to validate our tissue 917 relevance analysis. In many cases, the top-ranking tissue fits our prior expectation. However, we 918 also acknowledge that identifying relevant tissues from >100 tissue types is indeed a challenging 919 task. Specifically, for 34 out of 43 traits, the PPs for more than half of the tissues within the 920 corresponding top-ranking tissue group are greater than 0.5, suggesting that it is often difficult to 921 identify a single trait-relevant tissue within the tissue group. Alternative approaches to explore 922 fine-scale trait-tissue relevance have been suggested before. For example, a two-step analysis 923 procedure was proposed to first identify trait-relevant tissue group and then identify trait-relevant 924 tissue within the tissue group [80]. In addition, using synthetic annotations generated from Genoskyline [28] or FUN-LDA [81] could be particularly useful for identifying fine scale trait-926 relevant tissues. Our method can be easily adapted to incorporate a two-step analysis procedure 927 and/or accommodate synthetic annotations, and has the potential to yield better trait-tissue 928 relevance resolution in the future. 929 930 Finally, while we have mainly focused on inferring trait-relevant tissues, we have also explored 931 the feasibility of using inferred trait-relevant tissues and the estimated annotation coefficients to 932 enable more powerful SNP set test in future GWASs. In practice, multiple annotation sets can be 933 used to construct SNP set tests (e.g. HC and HB annotations sets as used in our real data 934 application). It is often difficult a priori to determine which annotation set would yield the best 935 results. Therefore, we recommend analyzing all of these annotation sets separately and choose 936 the one that yields the highest power, as we have done in the real data application. In addition, 937 sometimes the trait of interest may have multiple relevant tissues. In this case, we can apply the 
